Since 2006, the Phospholipid Research Center has been funding research into phospholipid excipients in drugs

Drug Delivery
All categoriesBasic ResearchDepotDermalDrug DeliveryOralParenteral
All aggregates
CochleatesColloidsEmulsionsExosomesExtrudatesImplantsLipodisksLiposomesMicrobubblesMixed Micelles / MicellesMonolayerPolymer Nanofibers / NanofibersSelf-assembling NanoparticlesSelf-emulsifying SystemsSolid Dispersions / DispersionsTablets
Any status
finishedongoing
Drug Delivery, Parenteral

Lipid nanovectors to use non-coding RNA oligonucleotides in glioblastoma in combination with standard therapy – part II

Prof. Dr. G. De Rosa, University Frederico II Naples/Italy

Since 2020
Drug Delivery, Parenteral

Targeted liposomal drug delivery to pediatric sarcomas: beyond the EPR effect

PD Dr. M. Bernasconi, University of Bern/Switzerland

Since 2020
Drug Delivery, Parenteral

Bioactive liposomes for the treatment of Non-Alcoholic SteatoHepatitis (NASH)

Assist.Prof. Dr. R. Bansal, University Twente/The Netherlands

Since 2019
Drug Delivery, Parenteral

Co-amorphous drug-lecithin systems – bridging the gap between amorphous solid disperions and lipid based drug delivery

Prof. Dr. Dr. h.c. Th. Rades, University of Copenhagen/Denmark

Since 2019
Drug Delivery, Oral

Enabling oral delivery of peptides by designing phospholipid complexes for self-emulsifying drug delivery systems

Prof. Dr. A. Müllertz, University of Copenhagen/Denmark

Since 2019
Drug Delivery, Oral

Improving nano-particulate carriers for oral drug delivery using archaeal tetraether lipids from novel sources

Assoc.Prof. Dr. A. Treusch, University of Southern Denmark/Denmark

Since 2019
Drug Delivery, Parenteral

Lipodisks for dual delivery of chemothereptuic drugs and anticancer peptides

Prof. Dr. K. Edwards, Uppsala University/Sweden

Since 2019
Drug Delivery, Oral

Oral mixed micelle formulations – a novel phospholipid-based platform for safe and effective pediatric drug delivery

Prof. Dr. S. Klein, University of Greifswald/Germany

Since 2019
Drug Delivery, Parenteral

Twin-screw extruded phospholipid implants for controlled parenteral delivery

Prof. Dr. R. Bodmeier and Dr. M. Kolbina, FU Berlin/Germany

Since 2019
Drug Delivery, Oral

Development of phospholipid based depot antimalarial tablets of azadirachta indica leaf extract and artemether/lumefantrine for oral delivery

Prof. Dr. A. A. Attama, University of Nigeria/Africa

Since 2018
Drug Delivery, Parenteral

Lipid nanovectors to use non-coding RNA oligonucleotides in glioblastoma in combination with standard therapy

Prof. Dr. G. De Rosa, University Frederico II Naples/Italy

2017–2019
Dermal, Drug Delivery

Synergy-based delivery system for combating sexually-transmitted bacterial infections: liposomal azithromycin-in-chitosan hydrogel

Assoc. Prof. Dr. Z. Vanić, University Zagreb/Croatia

2017–2018
Depot, Drug Delivery, Parenteral

Development of a phospholipid-based depot technology for sustained drug release

Prof. Dr. P. Luciani, University Jena/Germany, now: University Bern/Switzerland

2016-2020
Basic Research, Dermal, Drug Delivery

Investigation of liposomal transdermal drug delivery by Raman microscopic imaging in combination with stable isotopic labelling as a new non-invasive modality to study drug penetration

Dr. Ch. Matthaeus, University Jena/Germany

Since 2016
Basic Research, Drug Delivery

On-demand amplification of chemotherapy by ultra-fast drug release from plasmonic liposomes

Dr. Xiuying Li, University of Dallas/USA

2016–2018
Drug Delivery, Parenteral

Improving treatment of pediatric sarcomas through targeted liposomal drug delivery

Dr. M. Bernasconi, University Children’s Hospital Zurich/Switzerland

2015–2017
Drug Delivery, Oral

Elucidating the use of lyso-phospholipids in oral self-nanoemulsifying drug delivery systems

Prof. Dr. A. Müllertz, Copenhagen/Denmark

2013–2017
Drug Delivery, Parenteral

A lipid based drug delivery system for CNS applications

Dr. V. Reichel, University of Heidelberg/Germany

2010–2012